466 related articles for article (PubMed ID: 28050782)
1. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR
Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
[TBL] [Abstract][Full Text] [Related]
3. Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
Samadder NJ; Valentine JF; Guthery S; Singh H; Bernstein CN; Leighton JA; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Burt RW; Curtin K; Smith KR
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1807-1813.e1. PubMed ID: 30267862
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
5. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
[TBL] [Abstract][Full Text] [Related]
6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
Birch RJ; Burr N; Subramanian V; Tiernan JP; Hull MA; Finan P; Rose A; Rutter M; Valori R; Downing A; Morris EJA
Am J Gastroenterol; 2022 Nov; 117(11):1858-1870. PubMed ID: 36327438
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of inflammatory bowel disease.
Burisch J; Munkholm P
Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
13. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenesis in inflammatory bowel disease.
Herszenyi L; Miheller P; Tulassay Z
Dig Dis; 2007; 25(3):267-9. PubMed ID: 17827953
[TBL] [Abstract][Full Text] [Related]
15. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
17. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
Everhov ÅH; Erichsen R; Järås J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
Aliment Pharmacol Ther; 2022 Oct; 56(7):1168-1182. PubMed ID: 35916190
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
20. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]